These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 411000)

  • 1. The effect of TRH and a related tripeptide, L-N-(2-oxopiperidin-6-yl-carbonyl)-L-histidyl-L-thiazolidine-4-carboxamide (MK-771, OHT), on the depressant action of barbiturates and alcohol in mice and rats.
    Porter CC; Lotti VJ; de Felice MJ
    Life Sci; 1977 Sep; 21(6):811-20. PubMed ID: 411000
    [No Abstract]   [Full Text] [Related]  

  • 2. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
    Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
    Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs.
    Breese GR; Cott JM; Cooper BR; Prange AJ; Lipton MA; Plotnikoff NP
    J Pharmacol Exp Ther; 1975 Apr; 193(1):11-22. PubMed ID: 805836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of neurotensin on the actions of barbiturates and ethanol.
    Luttinger D; Frye GD; Bissette G
    Ann N Y Acad Sci; 1982; 400():259-67. PubMed ID: 6820242
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the neuropharmacology of thyrotropin releasing hormone (TRH) and a new TRH analog.
    Yarbrough GG
    Eur J Pharmacol; 1978 Mar; 48(1):19-27. PubMed ID: 416961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats.
    Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K
    Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a new TRH analogue, YM-14673 on the central nervous system.
    Yamamoto M; Shimizu M
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):561-5. PubMed ID: 3125485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of TRH on the central nervous system of the rabbit.
    Horita A; Carino MA; Smith JR
    Pharmacol Biochem Behav; 1976; 5(Suppl 1):111-6. PubMed ID: 138141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-butyrolactone-gamma-carbonyl-histidyl-prolinamide citrate (DN-1417): a novel TRH analog with potent effects on the central nervous system.
    Miyamoto M; Fukuda N; Narumi S; Nagai Y; Saji Y; Nagawa Y
    Life Sci; 1981 Feb; 28(8):861-9. PubMed ID: 6783804
    [No Abstract]   [Full Text] [Related]  

  • 10. TRH and its novel analog (DN-1417): antipentobarbital action and involvement of cholinergic mechanisms.
    Miyamoto M; Nagai Y; Narumi S; Saji Y; Nagawa Y
    Pharmacol Biochem Behav; 1982 Oct; 17(4):797-806. PubMed ID: 6817348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the analeptic potency of TRH, ACTH 4-10, LHRH, and related peptides.
    Bissette G; Nemeroff CB; Loosen PT; Prange AJ; Lipton MA
    Pharmacol Biochem Behav; 1976; 5(Suppl 1):135-8. PubMed ID: 189324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of thyrotropin releasing hormone, MK-771 and DN-1417 on morphine abstinence syndrome.
    Bhargava HN; Matwyshyn GA
    Psychopharmacology (Berl); 1985; 87(2):141-6. PubMed ID: 2996045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to ethanol and cross-tolerance to pentobarbital and barbital.
    Gougos A; Khanna JM; Lê AD; Kalant H
    Pharmacol Biochem Behav; 1986 Apr; 24(4):801-7. PubMed ID: 3714775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog, (I): Effects on the central nervous system by oral administration.
    Yamamura M; Kinoshita K; Nakagawa H; Tanaka T; Maeda K; Ishida R
    Jpn J Pharmacol; 1990 Aug; 53(4):451-61. PubMed ID: 2120494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of thyrotropin-releasing hormone on behavioral disturbances in middle cerebral artery-occluded rats.
    Yamamoto M; Tamura A; Kirino T; Shimizu-Sasamata M; Sano K
    Eur J Pharmacol; 1991 May; 197(2-3):117-23. PubMed ID: 1915564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a new analogue of thyrotropin-releasing hormone on pentobarbital-induced sleeping time in rodents.
    Yamamoto M; Shimizu M
    Neuropharmacology; 1989 Aug; 28(8):863-6. PubMed ID: 2506487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin-releasing hormone stimulates release of arginine vasopressin and oxytocin in vivo.
    Weitzman RE; Firemark HM; Glatz TH; Fisher DA
    Endocrinology; 1979 Apr; 104(4):904-7. PubMed ID: 108088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thyrotropin-releasing hormone and its analogue L-6-ketopiperidine-2-carbonyl-leucyl-L-prolin-amide on behaviour and electroencephalogram.
    Sarkadi A; Szabo S; Laszy J; Ambrus A; Szporny L
    Arzneimittelforschung; 1988 Aug; 38(8):1134-8. PubMed ID: 3143370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of thyrotropin releasing hormone and its analogues on unconsciousness following head injury in mice.
    Tanaka K; Ogawa N; Chou H; Mori A; Yanaihara N
    Regul Pept; 1992 Mar; 38(2):129-33. PubMed ID: 1574607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin-releasing hormone (TRH) potentiates pentobarbital-based flavor aversion learning.
    Taukulis HK
    Behav Neural Biol; 1983 Sep; 39(1):135-9. PubMed ID: 6419719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.